Clinical Trial Update: TAA Specific Cytotoxic T Lymphocytes in Patients With Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating tumor-associated antigen-specific cytotoxic T lymphocytes in pancreatic cancer has completed. Results were posted in August …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• TAA-specific cytotoxic T lymphocytes

Snippet

Sponsor: Baylor College of Medicine | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-08-01